Search Results - "Oflazoğlu, Utku"

The relationship between sarcopenia and serum irisin and TNF-α levels in newly diagnosed cancer patients by Demir, Leyla, Oflazoğlu, Utku

“…Objective Sarcopenia in patients with cancer makes patients physically weak and adversely affects their compliance with treatment. In this study, we…”
Get full text

Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients by Güç, Zeynep Gülsüm, Alacacıoğlu, Ahmet, Yazır, Merve Güleç, Kalender, Mehmet Eren, Ünal, Sinan, Oflazoğlu, Utku, Yıldız, Yaşar, Salman, Tarık, Küçükzeybek, Yüksel, Ellidokuz, Hülya, Tarhan, Mustafa Oktay

“…In this study, we aimed to assess anxiety and sleep quality in cancer patients treated or followed up at our clinic at the time of the outbreak of the COVID-19…”
Get more information

The Epidermal Growth Factor, Anaplastic Lymphoma Kinase, and ROS Proto-oncogene 1 Mutation Profile of Non-Small Cell Lung Carcinomas in the Turkish Population: A Single-Center Analysis by Gün, Eylül, Çakır, İzzetiye Ebru, Ersöz, Hasan, Oflazoğlu, Utku, Sertoğullarından, Bünyamin

“…The management of non-small cell lung carcinomas (NSCLC) has changed with the identification of molecular pathways. We aimed to reveal the 3-year epidermal…”
Get full text

HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) study by Güç, Zeynep Gülsüm, Alacacıoğlu, Ahmet, Kalender, Mehmet Eren, Oflazoğlu, Utku, Ünal, Sinan, Yıldız, Yaşar, Salman, Tarık, Küçükzeybek, Yüksel, Tarhan, Mustafa Oktay

“…Objective The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and the Geriatric Nutrition Risk Index (GNRI) are used as prognostic factors in…”
Get full text

Prevalence and related factors of sarcopenia in newly diagnosed cancer patients by Oflazoglu, Utku, Alacacioglu, Ahmet, Varol, Umut, Kucukzeybek, Yuksel, Salman, Tarik, Taskaynatan, Halil, Yildiz, Yasar, Ozdemir, Ozlem, Tarhan, MustafaOktay

“…Introduction Sarcopenia is defined as the loss of muscle mass and muscular functioning. Although sarcopenia prevalence is highly variable in the literature,…”
Get full text

Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) study by Oflazoglu, Utku, Alacacioglu, Ahmet, Varol, Umut, Kucukzeybek, Yuksel, Salman, Tarik, Taskaynatan, Halil, Yildiz, Yasar, Saray, Seray, Tarhan, M. Oktay

“…Background Sarcopenia is associated with physical disability, increased post-operative complications, poorer tolerance to chemotherapy, and reduced survival…”
Get full text

The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study) by Oflazoglu, Utku, Alacacioglu, Ahmet, Varol, Umut, Kucukzeybek, Yuksel, Salman, Tarik, Onal, Hulya Tas, Yilmaz, Huriye Erbak, Yildiz, Yasar, Taskaynatan, Halil, Saray, Seray, Butun, Osman, Tarhan, M. Oktay

“…Introduction Although the chemotherapy-induced sarcopenia has some explanatory presence in clinical practice, the mechanisms underlying this phenomenon have…”
Get full text

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology by Berk, Veli, Kaplan, Mehmet Ali, Tonyali, Onder, Buyukberber, Suleyman, Balakan, Ozan, Ozkan, Metin, Demirci, Umut, Ozturk, Turkan, Bilici, Ahmet, Tastekin, Didem, Ozdemir, Nuriye, Unal, Olcun Umit, Oflazoglu, Utku, Turkmen, Esma, Erdogan, Bulent, Uyeturk, Ummugul, Oksuzoglu, Berna, Cinkir, Havva Yesil, Yasar, Nurgul, Gumus, Mahmut

“…Inoperable and metastatic hepatocellular carcinoma (HCC) is associated with a poor prognosis and low chemotherapeutic efficiency. Sorafenib is an oral…”
Get full text

Is monitoring mean platelet volume necessary in breast cancer patients? by Taskaynatan, Halil, Alacacioglu, Ahmet, Kucukzeybek, Yuksel, Varol, Umut, Yildiz, Yasar, Salman, Tarik, Oflazoglu, Utku, Tarhan, Mustafa Oktay

“…Mean platelet volume (MPV) is a parameter that increases during thrombotic and cardiovascular events. Tamoxifen (Tmx) and aromatase inhibitors (AIs), which are…”
Get full text

The relationship between sarcopenia and serum irisin and TNF-[alpha] levels in newly diagnosed cancer patients by Demir, Leyla, Oflazoglu, Utku

“…Objective Sarcopenia in patients with cancer makes patients physically weak and adversely affects their compliance with treatment. In this study, we…”
Get full text

The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients by Yildiz, Ibrahim, Taskaynatan, Halil, Varol, Umut, Salman, Tarik, Oflazoglu, Utku, Yildiz, Yasar, Kucukzeybek, Yuksel, Alacacioglu, Ahmet, Tarhan, Mustafa Oktay

“…The use of FOLFOXIRI (oxaliplatin, irinotecan, leucovorin, and 5-fluorouracil) as first-line therapy for metastatic colorectal cancer (mCRC) is…”
Get full text

Treatment Strategies for Glioblastoma Multiforme: A Single Center Experience by SARAY, Seray, SALMAN, Tarık, KORKMAZ, Uğur Bayram, ÜZÜM, Yusuf, ÜNAL, Sinan, GÜÇ, Zeynep Gülsüm, YILDIZ, Yaşar, OFLAZOĞLU, Utku, ŞENGÜL, Adem, KÜÇÜKZEYBEK, Yüksel, ALACACIOĞLU, Ahmet

Get full text

Case report of a renal cell carcinoma patient with acute pancreatitis under both sunitinib and axitinib treatment by Oflazoglu, Utku, Varol, Umut, Alacacioglu, Ahmet, Salman, Tarik, Demir, Necla, Semiz, Huseyin Salih, Karaoglu, Aziz, Oztop, Ilhan

“…Sunitinib and axitinib are oral tyrosine kinase inhibitors (TKI) that is commonly used in the treatment of metastatic renal cell carcinoma (RCC) as it has been…”
Get full text

Atypical Presentation of a Primary Thymic Adenocarcinoma by Ersoz, Hasan, Cakir, Ebru, Oflazoglu, Utku, Dernek, Berna

“…Primary thymic adenocarcinomas are extremely rare and aggressive tumours. In this report, clinical and histopathological findings of this rare entity as well…”
Get full text

Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The İzmir oncology group (IZOG) study by Taşkaynatan,Halil, Küçükzeybek,Yüksel, Yıldız,Yaşar, Salman,Tarık, Oflazoğlu,Utku, Varol,Umut, Alacacıoğlu,Ahmet, Saray,Seray, Özdemir,Özlem, Tarhan,Mustafa Oktay

“…Aim: Oral etoposide dosage is roughly 50-100 mg/m2 on days 1 to 21 every 28 days. However, dosage of 50 mg/day oral etoposide for five days a week is not well…”
Get full text

Regorafenib therapy as a third-line treatment for metastatic colorectal cancer: A single center long term experience by Ozkan, Merve, Oflazoglu, Utku, Yildiz, Yaşar, Güc, Zeynep G, Salman, Tarik, Ünal, Sinan, Kücükzeybek, Yüksel, Alacacioglu, Ahmet

“…This study examined the effects of regorafenib (Reg) on progression-free survival (PFS), overall survival (OS), and adverse events (AEs) in metastatic…”
Get full text

The role of inflammation in adjuvant chemotherapy-induced sarcopenia by Oflazoglu, Utku, Alacacioglu, Ahmet, Varol, Umut, Kucukzeybek, Yuksel, Salman, Tarik, Onal, Hulya Tas, Yilmaz, Huriye Erbak

“…Introduction Although the chemotherapy-induced sarcopenia has some explanatory presence in clinical practice, the mechanisms underlying this phenomenon have…”
Get full text

Prognostic value of De Ritis ratio (aspartate transaminase/alanine transaminase) in patients with non-metastatic colorectal carcinoma [izmir oncology group(IZOG) study] by Oflazoglu, Utku, Insan, Temmuz Gurdal, Kucukzeybek, Yuksel, Varol, Umut, Salman, Tarik, Yildiz, Yasar, Saray, Seray, Butun, Osman, Taskaynatan, Halil, Bolat Kucukzeybek, Betul, Alacacioglu, Ahmet

“…Abstract only e16114 Background: We aimed to assess the prognostic effect of preoperative De Ritis (aspartate aminotransaminase/Alanine aminotransaminase)…”
Get full text

The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients by Uzum, Yusuf, Salman, Tarik, Oflazoglu, Utku, Yildiz, Yasar, Varol, Umut, Aysin, Murat, Kucukzeybek, Yuksel, Alacacioglu, Ahmet, Tarhan, Mustafa Oktay

“…Individuals with a higher De Ritis ratio (aspartate transaminase/alanine transaminase) and neutrophil-to-lymphocyte ratio (NLR) have an inferior survival in…”
Get full text

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study by Salman, Tarik, Kazaz, Seher Nazli, Varol, Umut, Oflazoglu, Utku, Unek, Ilkay Tugba, Kucukzeybek, Yuksel, Alacacioglu, Ahmet, Atag, Elif, Semiz, Huseyin Salih, Cengiz, Hakan, Oztop, Ilhan, Tarhan, Mustafa Oktay

“…Several studies evaluating the prognostic factors of gastrointestinal and pancreatic neuroendocrine tumors (GEP-NETs) have been published. The…”
Get more information